Physician profile
Kelly A Watson
NPI 1942529516
$6,024.90
in general payments reported to CMS, 2019-2025
8 companies · $2,762 in 2025
The $2,762 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $97.18 · 2023: $1,205 · 2024: $1,961 · 2025: $2,762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,779 · Honoraria: $1,650 · Food and Beverage: $1,399 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,779.13 |
| Honoraria | $1,650.00 |
| Food and Beverage | $1,398.59 |
| Education | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maquet Cardiovascular L.L.C. | $1,912.60 | 2025 | Vasoview Hemopro 2 |
| Terumo Cardiovascular Systems Corporation | $1,296.96 | 2022-2024 | Harvest, Virtuosaph Plus With Radial Indication |
| Getinge USA Sales, LLC | $1,164.02 | 2024-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Atricure, INC. | $897.56 | 2023-2024 | |
| Intuitive Surgical, INC. | $376.71 | 2025 | |
| Medical Device Business Services, INC. | $275.18 | 2024 | Ethicon, Stratafix, Vistaseal |
| Arthrex, INC. | $59.54 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $42.33 | 2023 | Tagrisso |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.